Blue Bell Private Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-432
Closed -$38.8K – 745
2025
Q1
$38.8K Buy
432
+296
+218% +$26.5K 0.01% 405
2024
Q4
$10.9K Buy
136
+6
+5% +$519 ﹤0.01% 494
2024
Q3
$11.7K Buy
130
+56
+76% +$4.71K ﹤0.01% 510
2024
Q2
$5.83K Hold
74
– – ﹤0.01% 562
2024
Q1
$6.45K Buy
74
+3
+4% +$256 ﹤0.01% 552
2023
Q4
$5.85K Hold
71
– – ﹤0.01% 550
2023
Q3
$5.56K Sell
71
-50
-41% -$4.19K ﹤0.01% 490
2023
Q2
$10.7K Hold
121
– – ﹤0.01% 408
2023
Q1
$9.76K Hold
121
– – ﹤0.01% 380
2022
Q4
$9.4K Sell
121
-75
-38% -$6.08K ﹤0.01% 381
2022
Q3
$16K Hold
196
– – 0.01% 324
2022
Q2
$18K Hold
196
– – 0.01% 328
2022
Q1
$22K Sell
196
-11
-5% -$1.16K 0.01% 312
2021
Q4
$21K Buy
+207
New +$24K 0.01% 304

Other funds holding MDT

Blue Bell Private Wealth Management's MDT Position: Q2 2025 in Review

Blue Bell Private Wealth Management sold out of Medtronic (MDT) in Q2 2025, closing a stake of 432 shares — an estimated $38.8K sold.

Blue Bell Private Wealth Management first reported a position in MDT in Q4 2021 and held it in 14 quarters. The position peaked at $38.8K in Q1 2025. 2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Blue Bell Private Wealth Management reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 432 Medtronic shares in Q2 2025, an estimated $38.8K.
  • Blue Bell Private Wealth Management first reported a position in Medtronic in Q4 2021 and held it in 14 quarters.
  • Blue Bell Private Wealth Management's Medtronic position peaked at $38.8K in Q1 2025.
  • 2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.